Navigation Links
Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic
Date:10/27/2010

PRINCETON, N.J., Oct. 27 /PRNewswire/ -- Laureate Pharma, Inc., a full-service contract development and manufacturing organization, announced today that they have entered into a development and manufacturing agreement to produce AV-203, AVEO Pharmaceutical's (Cambridge, MA) novel monoclonal antibody targeted against ErbB3.  Laureate's services will include process development, protein production, purification and aseptic filling of AP-203 for AVEO.  The project is presently underway and Laureate expects to supply AVEO with clinical product in the second quarter of 2011.  Terms of the manufacturing agreement were not disclosed.

"AVEO has a very impressive pipeline of monoclonal antibody-based products for treatment of cancer and we are pleased to work with them on this exciting antibody product," said Steve Johnson, Vice President, Business Development, of Laureate Pharma.  "We look forward to a productive and successful relationship with AVEO to provide clinical supply of their monoclonal antibodies."

AV-203 is an ErbB3 (HER3)-targeted antibody. ErbB3 belongs to a family of four proteins that also includes the epidermal growth factor receptor (EGFR) and the HER2 receptor. Both EGFR and HER2 have been implicated in promoting the growth of significant numbers of tumors, particularly in breast and lung cancers. Drugs blocking the activity of EGFR have demonstrated clinical benefit in lung, colon and head and neck cancers, while drugs targeting HER2 show clinical benefit in the treatment of HER2 over-expressing breast cancers. ErbB3 is significantly over-expressed in many human breast, ovarian, prostate, colorectal, pancreatic, gastric, and head and neck cancers, which generally correlates with poor prognosis.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical contract development and manufacturing organization. Laureate's scientists are expert in process development and cGMP production of
'/>"/>

SOURCE Laureate Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
2. Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
3. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
4. Thomson Reuters Predicts Nobel Laureates
5. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
6. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
7. As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed
8. Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical
9. Teva Pharmaceuticals and the Philadelphia Eagles Award Four Grants to Greater Philadelphia Area Service Organizations
10. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
11. CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... 8, 2011 Ness County Hospital is moving ... the implementation of Prognosis ChartAccess® Comprehensive EHR, the ... federal government,s meaningful use requirements as stipulated under ... At the same time, the Ness ...
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Tuesday, February 15, 2011.  The presentation is scheduled for ... through the Company,s web site, www.regeneron.com , on ... presentation will be available after the live webcast through ...
Cached Medicine Technology:Ness County Hospital Selects ChartAccess® Comprehensive EHR from Prognosis Health Information Systems 2Ness County Hospital Selects ChartAccess® Comprehensive EHR from Prognosis Health Information Systems 3
(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... a review published in the April issue of ... Feinstein Institute for Medical Research, says it,s time to ... approach to treating sepsis, which kills millions worldwide ... occurs when molecules released into the bloodstream to fight ... Inflammation is necessary for maintaining good health without ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
(Date:4/17/2014)... potential to ward off depression among retirees, particularly among ... in The Journals of Gerontology, Series B: ... article " Internet Use and Depression Among Retired Older ... the authors report that Internet use reduced the probability ... study sample. , Late-life depression affects between 5 ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Internet use may cut retirees' depression 2
... study in the May 1 issue of the journal SLEEP ... sample of exceptionally old adults, including nearly 2,800 people who were ... 65 percent of the sample reported that their sleep quality was ... was about 7.5 hours including naps. Surprisingly, the ...
... ... releases statement on Intellectual Property Day , ... (PRWEB) April 30, 2010 -- Ranjit Shahani, President of the Organization ... the effect drug patent protection is having on innovation in India: , , ,Emotion tends ...
... say C. gattii not infecting as many as ... News) -- The new "killer" fungus spreading through the Pacific ... , "It,s definitely real in that we,ve been seeing this ... lot more meningitis than you would expect in the general ...
... ... designed for any athlete requiring therapy for fatigued or overused shoulder and elbows. ... Dallas, TX (PRWEB) May 2, ... for fatigued or overused shoulder and elbows. This great new product was named Best of ...
... had no adverse effects, researchers say , FRIDAY, April ... and Flumadine appear to be safe for pregnant women ... analyzed the medical records of 239 pregnant women who ... with one of the three drugs. Among these patients, ...
... in running, catching, throwing lead to sedentary lifestyle, study ... than three-quarters of disadvantaged preschool children in the United ... running, jumping, throwing and catching, a new study finds. ... giving up on physical activity and becoming obese teens ...
Cached Medicine News:Health News:Sleeping well at 100 years of age: Study searches for the secrets to healthy longevity 2Health News:Drug Patents in India Helping Promote Innovation 2Health News:Drug Patents in India Helping Promote Innovation 3Health News:'Killer' Fungus Not So Deadly 2Health News:'Killer' Fungus Not So Deadly 3Health News:Chilly-Billy Ice Compress - Arm Care for Athletes 2Health News:Chilly-Billy Ice Compress - Arm Care for Athletes 3Health News:Taking Flu Drugs While Pregnant Appears to Be Safe: Study 2Health News:Motor Skills Lag in Poor Preschoolers 2
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: